Abbott Laboratoriesvs.Bio-Rad Laboratories
ABT vs BIO · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Abbott Laboratories is about 21× larger than Bio-Rad Laboratories by market cap; Abbott Laboratories trades at the lower P/E (26.1 vs 47.1); year to date, Bio-Rad Laboratories leads (−2.3% vs −25.0%).
Side by side
| ABT | BIO | |
|---|---|---|
| Market cap | $164B | $8B |
| Price | $93.93 | $296.11 |
| Today | −0.5% | −0.4% |
| Return YTD | −25.0% | −2.3% |
| Return 1Y | −29.7% | +13.9% |
| P/E | 26.1 | 47.1 |
| P/S | 3.6 | 3.1 |
| P/B | 3.1 | 1.2 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Abbott LaboratoriesABT
American healthcare group with four divisions: diagnostics, medical devices (including glucose monitoring), nutrition and generics.
Full ABT profile →Bio-Rad LaboratoriesBIO
American manufacturer of products for clinical diagnostics and life science research — including blood typing and droplet digital PCR.
Full BIO profile →More comparisons in Diagnostics
See where ABT and BIO sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →